A Composition comprising antibody specifically binding to BAG2 for the diagnosis of cancer and method using the same
WO2020165797A1
Methods for diagnosing cancer using anti-bag2 antibody
EP3813830A1
Methods of diagnosing and treating cancer patients expressing high levels of tgf-b response signature
KR20200098338A
An antibody or antigen-binding fragment thereof specifically binding to BAG2 polypeptide or fragment thereof
KR20200098329A
A Composition comprising antibody specifically binding to BAG2 for the diagnosis of cancer and method using the same
KR20190045638A
A method for the diagnosis of cancer using blood
WO2016163754A1
Pharmaceutical composition for preventing or treating cancer and method using thereof
WO2016126054A1
Composition for preventing or treating erectile dysfunction comprising modified dkk2 protein or gene therefor, and method using same
EP3253386A1
Pharmaceutical composition for preventing or treating chronic myeloid leukemia and method using the same
KR20160120157A
Pharmaceutical composition for preventing or treating cancer and method using thereof
KR20140089003A
A colon cancer specific polynucleotide and use thereof
EP2647637A2
Purinylpyridinylamino-2,4-difluorophenyl sulfonamide derivative, pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition with inhibitory activity against raf kinase, containing same as active ingredient
